Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001739074-20-000012
Filing Date
2020-10-13
Accepted
2020-10-13 16:54:40
Documents
1
Effectiveness Date
2020-10-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15007
  Complete submission text file 0001739074-20-000012.txt   16123
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-377769 | Film No.: 201236923
SIC: 2834 Pharmaceutical Preparations